SCHEMBL7401909

SCHEMBL7401909

Oc1ccccc1OCCN1CCC(Cc2ccc(F)cc2)CC1

nearest known ligand 0.69

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.58
MEN1 O00255 2/20 0.58
KMT2A Q03164 2/20 0.58
ALDH1A1 P00352 1/20 0.58
SMN1; SMN2 Q16637 1/20 0.58
NPSR1 Q6W5P4 1/20 0.58
SLC6A2 P23975 1/20 0.58
SLC6A4 P31645 1/20 0.58
SLC6A3 Q01959 1/20 0.58
TMEM97 Q5BJF2 1/20 0.57
SIGMAR1 Q99720 1/20 0.57
DRD4 P21917 2/20 0.52
MAOB P27338 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7407347 0.99 KDM4E (0.57) KDM4EMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL7399889 0.91 TMEM97 (0.69) KDM4EMEN1KMT2AALDH1A1SMN1; SMN2
Hydrochloric Acid SCHEMBL7403750 0.90 TMEM97 (0.67) KDM4EMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL7398122 0.89 KDM4E (0.64) KDM4EMEN1KMT2AALDH1A1SMN1; SMN2
Hydrochloric Acid SCHEMBL7403706 0.88 KDM4E (0.62) KDM4EMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL5816816 0.82 LTA4H (0.59) KDM4EMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL7400101 0.82 TMEM97 (0.70) SLC6A2SLC6A4SLC6A3TMEM97SIGMAR1
SCHEMBL3926715 0.81 TMEM97 (0.62) SLC6A2SLC6A4SLC6A3TMEM97SIGMAR1
SCHEMBL7397997 0.81 TMEM97 (0.62) SLC6A2SLC6A4SLC6A3TMEM97SIGMAR1
SCHEMBL7408283 0.81 DRD4 (0.55) KDM4EMEN1KMT2AALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0869792-A4 4-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE SELECTIVE NMDA RECEPTOR ANTAGONISTS WARNER LAMBERT CO (US) 1999-09-22 EP claimed
EP-0869792-A2 4-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE SELECTIVE NMDA RECEPTOR ANTAGONISTS WARNER-LAMBERT COMPANY (US) 1998-10-14 EP claimed
WO-1997023216-A1 4-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE SELECTIVE NMDA RECEPTOR ANTAGONISTS WARNER-LAMBERT COMPANY (US) 1997-07-03 WO claimed
US-6124323-A ACTIVE DRUG TREATING STROKE, CEREBRAL ISCHEMIA, CENTRAL NERVOUS SYSTEM TRAUMA, HYPOGLYCEMIA, ANXIETY, CONVULSIONS, AMIOGLYCOSIDE ANTIBIOTICS-INDUCED HEARING LOSS, MIGRAINE HEADACHES, CHRONIC PAIN, GLAUCOMA, CMV RETINITIS, PSYCHOSIS WARNER-LAMBERT COMPANY (US) 2000-09-26 US disclosed
EP-0869792-A4 4-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE SELECTIVE NMDA RECEPTOR ANTAGONISTS WARNER LAMBERT CO (US) 1999-09-22 EP disclosed
EP-0869792-A2 4-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE SELECTIVE NMDA RECEPTOR ANTAGONISTS WARNER-LAMBERT COMPANY (US) 1998-10-14 EP disclosed
WO-1997023216-A1 4-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE SELECTIVE NMDA RECEPTOR ANTAGONISTS WARNER-LAMBERT COMPANY (US) 1997-07-03 WO disclosed